Literature DB >> 9814581

Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice.

J A Yang-Snyder1, E V Rothenberg.   

Abstract

In situ hybridization and immunohistochemistry were used to determine the spectrum of tissues in which interleukin-2 (IL-2) mRNA and protein are found in healthy, normal young mice. In neonatal animals, IL-2 is expressed specifically by distinct, isolated cells at three major sites: the thymus, skin, and gut. Based on morphology and distribution, the IL-2-expressing cells resemble CD3epsilon+ T cells that are also present in all these locations. Within the thymus of postweanling animals, both TcRalphabeta and TcRgammadelta lineage cells secrete "haloes" of the cytokine that diffuse over many cell diameters. Within the skin, isolated cells expressing IL-2 are seen at birth in the mesenchyme, and large numbers of IL-2-expressing cells are localized around hair follicles in the epidermis in 3-week-old animals. At this age, a substantial subset of CD3epsilon+ cells is similarly localized in the skin. Significantly, by 5 weeks of age and later when the CD3epsilon+ cells are evenly distributed throughout the epidermis, IL-2 RNA and protein expression are no longer detectable. Finally, within the intestine, IL-2 protein is first detected in association with a few discrete, isolated cells at day 16 of gestation and the number of IL-2 reactive cells increases in frequency through E19 and remains abundant in adult life. In postnatal animals, the frequency of IL-2-positive cells in villi exceeds by greater than fivefold that found in mesenteric lymph node or Peyer's patches. Overall, these temporal and spatial patterns of expression provide insight into the regulation of IL-2 in vivo and suggest a role for IL-2 expression distinct from immunological responses to antigen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814581      PMCID: PMC2275993          DOI: 10.1155/1998/12421

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  9 in total

Review 1.  Caffey disease: new perspectives on old questions.

Authors:  Harikiran Nistala; Outi Mäkitie; Harald Jüppner
Journal:  Bone       Date:  2013-12-31       Impact factor: 4.398

2.  IL-2 prevents deletion of developing T-regulatory cells in the thymus.

Authors:  Daniel Y Hu; Rushika C Wirasinha; Christopher C Goodnow; Stephen R Daley
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

3.  Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis.

Authors:  David L Owen; Shawn A Mahmud; Kieng B Vang; Ryan M Kelly; Bruce R Blazar; Kendall A Smith; Michael A Farrar
Journal:  J Immunol       Date:  2018-05-04       Impact factor: 5.422

4.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 5.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

6.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

7.  Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.

Authors:  Matthew A Burchill; Jianying Yang; Kieng B Vang; James J Moon; H Hamlet Chu; Chan-Wang J Lio; Amanda L Vegoe; Chyi-Song Hsieh; Marc K Jenkins; Michael A Farrar
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

8.  Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice.

Authors:  Aase Ertesvag; Liv M I Austenaa; Harald Carlsen; Rune Blomhoff; Heidi Kiil Blomhoff
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

9.  Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine.

Authors:  L Loh; M A Ivarsson; J Michaëlsson; J K Sandberg; D F Nixon
Journal:  Mucosal Immunol       Date:  2014-03-19       Impact factor: 7.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.